Tag: Weight loss plateaus

According to clinical dosing guidelines, the initial dose of tirzepatide is a starter dose intended to help the body accustom itself to the medication. Therefore, it is normal and expected to see little to no weight loss when on this initial dose.

According to research, approximately 20-25% of patients experience significant weight regain or insufficient weight loss after bariatric surgery. For this reason, many patients and doctors are exploring how **is Ozempic affecting bariatric surgery**, and whether it can complement surgical efforts for more sustained results.